Press Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Get News Alerts by Email

Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Keywords Go

Advanced Search

Search

  Search Headlines Only

From

To

Asset Types

 Video  Audio  Photos  Documents  Events  Standard

 Basic Search

• Jun 6, 2012

  Trovagene and Strand Life Sciences Plan Collaboration to Validate and Offer Urine-Based HPV Screening Test in India and South Asia
• May 30, 2012

  Trovagene, Inc. Announces Pricing of Public Offering of 1,150,000 Units, Listing on NASDAQ and Effectiveness of Reverse Stock Split
• May 29, 2012

  Trovagene, Inc. Announces Pricing of Public Offering of 1,150,000 Units, Listing on NASDAQ and Effectiveness of Reverse Stock Split
• May 9, 2012

  Trovagene, Inc., Announces Issuance of European Patent for Detection of Pathogenic Infections
• May 1, 2012

  Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine

Show 5102550100 per page